Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan.
Frank Lloyd DiniErberto CarluccioRoberto BittoMichele CiccarelliMichele CorrealeAndreina D'AgostinoGiuseppe DattiloMarco FerrettiArianna GrelliStefania GuidaFrancesca JacoangeliLaura LupiLorenzo LuschiDaniele MasaroneValentina MercurioGiuseppe PacileoNicola Riccardo PuglieseAntonella RispoliLaura ScelsiCarlo Gabriele TocchettiNatale Daniele BrunettiAlberto PalazzuoliMassimo PiepoliSavina NodariGiuseppe Ambrosionull nullPublished in: ESC heart failure (2022)
Echocardiographically-derived haemodynamic classification identifies ambulatory HFrEF patients with different risk profiles. In real-world HFrEF outpatients, sacubitril/valsartan is effective in improving outcome across different haemodynamic profiles.